Group leaders talk with scientific and technical personnel and young employees
Release time:
2020-08-14
Group Leaders Discussed with Scientific and Technical Personnel and Young Employees
News # July 30 and 31 , 26 Scientific and Technical Personnel Representatives and 26 Young Employee Representatives from the Group and its subordinate enterprises respectively attended the Scientific and Technical Personnel Symposium and Young Employee Symposium of the Group Company. The leaders of the group company had face-to-face communication with them and listened to their opinions and suggestions. At the
symposium, the representatives combined their own job work, from the aspects of talent growth channels, employee training and learning, employee assessment and motivation, data and information sharing, communication and exchange, hardware facilities, business systems, working environment, transportation facilities, etc., Described their feelings and experiences in work and life, and put forward opinions and opinions. Chairman Jiang Xiaomeng, general manager Yu Jianhong and other company leaders respectively answered the representative questions raised by employee representatives, and said that these opinions and suggestions would be sorted out and classified, and fed back to relevant departments and units for improvement and solution. Chairman Jiang Xiaomeng introduced the company's industrial layout and future development ideas to the delegates. He hoped that employees could believe in the peak, plan their own development channels, strengthen learning, improve their business ability, seize opportunities, create conditions and do essential work well. At the same time, the company will also provide material and environmental equipment for the development of employees, form an atmosphere of advocating science and respecting scientific and technological personnel, increase effective training, design growth channels more scientifically, establish corresponding evaluation system and incentive system, enhance the combat effectiveness of the team, so as to enhance the competitiveness of enterprises.
General Manager Yu Jianhong analyzed the current economic situation and the company's strengths and weaknesses. He said that in the process of development and reform, enterprises need the efforts of young employees, especially the strength of young scientific and technological personnel. He hopes that young employees and scientific and technological personnel will strengthen their confidence in the future development of the peak and grow together with the peak; they must have enthusiasm and motivation for learning, further broaden their own careers, and improve the pattern; they must dare to face difficulties and setbacks, be good at persistence, and work Do the best.
It is the practice of the group company to hold scientific and technological personnel symposiums and young employees symposiums before the Spring Festival. In previous years, most of the employees' speeches were from a personal point of view, making demands and complaining more. However, in this year's symposium, employees are more likely to offer advice and suggestions from the perspective of enterprise management and development. There is such a change, on the one hand, due to the continuous progress of the company's management, the problems raised by the representatives in previous years have been effectively solved; on the other hand, it also reflects the improvement of staff quality and the ability to think about problems based on the overall situation. (Reporter
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page